
|Articles|October 23, 2007
FDA extends deadline for e-prescribing comments
Dec. 6 is new deadline for public comments regarding electronic distribution of prescribing information for Rx drugs.
Advertisement
Apparently not satisfied with the volume of comments it has received, the FDA has extended the comment period regarding electronic distribution of prescribing information for prescription drug products. The new deadline for comments, as published in the Oct. 22
Newsletter
Pharmacy practice is always changing. Stay ahead of the curve with the Drug Topics newsletter and get the latest drug information, industry trends, and patient care tips.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Drug Topics
1
Oral Semaglutide Show Promise as New Benchmark for Diabetes Care, Cardiovascular Protection
2
Limited Clinical Data Impact Cannabis Integration Into Standard Care | ASHP Midyear 2025
3
Opioid Overdose Deaths Fall by 34% in 2025 | ASHP Midyear 2025
4
Delgocitinib Improves Patients’ Chronic Hand Eczema
5




























































































































